{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:55:17Z","timestamp":1787028917373,"version":"build-2736575974"},"reference-count":46,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Faculty of Medicine of the Lithuanian University of Health Sciences"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Community-acquired pneumonia (CAP) remains a major health burden worldwide, with high morbidity and mortality, particularly among older adults and those with comorbidities. This study aimed to evaluate the etiological factors of CAP and to investigate systemic inflammatory markers (IL-6, IL-8, IFN-\u03b3, and G-CSF) in blood samples collected from CAP patients to identify which markers could be targets for potential etiological, clinical, and therapeutic interventions. Materials and Methods: A prospective study was conducted in 41 patients with confirmed CAP hospitalised during the winter season of 2024\u20132025. Clinical, demographic, and laboratory data were collected at admission and seven days later. Serum IL-6, IL-8, IFN-\u03b3, and G-CSF concentrations were measured using a multiplex assay. Results: Aetiology was identified in 87.8% of cases, with typical bacterial pathogens being more prevalent among older, smoking patients, while atypical pathogens were more common among younger, non-smoking patients. Hospitalisation and increased inflammatory markers were associated with older age. After seven days of treatment, significant decreases in IL-6, IFN-\u03b3, and G-CSF concentrations were observed. IFN-\u03b3 levels were significantly higher in patients with atypical aetiology. Higher concentrations of IL-8 and G-CSF were associated with hospitalisation. IL-6 levels were positively correlated with age, C-reactive protein (CRP), and pneumonia severity index (PSI) scores. Conclusions: Systemic inflammatory markers, especially IL-6, IL-8, IFN-\u03b3, and G-CSF, may be valuable tools in managing generalised pneumonia. They can help to differentiate etiologically, assess disease severity, and make treatment decisions.<\/jats:p>","DOI":"10.3390\/medicina61061078","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:18:40Z","timestamp":1749640720000},"page":"1078","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1268-7545","authenticated-orcid":false,"given":"Ruta","family":"Nutautiene","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0235-9378","authenticated-orcid":false,"given":"Irmantas","family":"Aleksa","sequence":"additional","affiliation":[{"name":"Centro Polyclinic, Naujamiestis Primary Personal Health Care Centre, Pylimo st. 3, LT-01117 Vilnius, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6745-4347","authenticated-orcid":false,"given":"Ieva","family":"Janulaityte","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0413-6808","authenticated-orcid":false,"given":"Erika","family":"Skrodeniene","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8933-5283","authenticated-orcid":false,"given":"Kristina","family":"Bieksiene","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Zaliaduonyte","sequence":"additional","affiliation":[{"name":"Lithuanian University of Health Sciences Kaunas Hospital, Josvainiu st. 2, LT-47144 Kaunas, Lithuania"},{"name":"Department of Cardiology, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44037 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Batulevicius","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6107-9731","authenticated-orcid":false,"given":"Astra","family":"Vitkauskiene","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Medicine, Academy of Medicine, Lithuanian University of Health Sciences, A. Mickeviciaus st. 9, LT-44307 Kaunas, Lithuania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s12325-020-01248-7","article-title":"Burden of Community-Acquired Pneumonia and Unmet Clinical Needs","volume":"37","author":"Sarda","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_2","unstructured":"World Health Organization (2025, May 17). WHO Reveals Leading Causes of Death and Disability Worldwide: 2000\u20132019. 9 December 2020. Available online: https:\/\/www.who.int\/news\/item\/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019."},{"key":"ref_3","unstructured":"World Health Organization (2025, May 17). Global Health Observatory (GHO) Data: Causes of Death. Available online: https:\/\/www.who.int\/data\/gho."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.medmal.2018.02.012","article-title":"Incidence of all-cause adult community-acquired pneumonia in primary care settings in France","volume":"48","author":"Partouche","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"ofy010","DOI":"10.1093\/ofid\/ofy010","article-title":"Incidence, aetiology, and outcomes of community-acquired pneumonia: A population-based study","volume":"5","author":"Bjarnason","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e019439","DOI":"10.1136\/bmjopen-2017-019439","article-title":"Incidence rate of community-acquired pneumonia in adults: A population-based prospective active surveillance study in three cities in South America","volume":"8","author":"Lopardo","year":"2018","journal-title":"BMJ Open"},{"key":"ref_7","first-page":"217","article-title":"Streptococcus pneumoniae: Epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Converso, T.R., Goulart, C., Rodriguez, D., Guerra, M.E.S., Darrieux, M., and Leite, L.C.C. (2022). Immune response induced in mice by a hybrid rPotD-PdT pneumococcal protein. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0273017"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1440-1843.2010.01814.x","article-title":"Pneumococci: Immunology of the innate host response","volume":"15","author":"Paterson","year":"2010","journal-title":"Respirology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijmr.IJMR_1582_16","article-title":"Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Jiang, Z., Li, S., Zhu, C., Zhou, R., and Leung, P.H.M. (2021). Mycoplasma pneumoniae infections: Pathogenesis and vaccine development. Pathogens, 10.","DOI":"10.3390\/pathogens10020119"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.aller.2017.09.021","article-title":"Mycoplasma pneumoniae and toll-like receptors: A mutual avenue","volume":"46","author":"Naghib","year":"2018","journal-title":"Allergol. Immunopathol. (Madr)"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jmii.2020.10.002","article-title":"Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children","volume":"54","author":"Tsai","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Yang, M., Meng, F., Gao, M., Cheng, G., and Wang, X. (2019). Cytokine signatures associate with disease severity in children with Mycoplasma pneumoniae pneumonia. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-54313-9"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Mei, S., Zhou, Y., Yang, D., Pan, T., Chen, Z., and Wang, Q. (2017). TIPE2 negatively regulates mycoplasma pneumonia-triggered immune response via MAPK signaling pathway. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-13825-y"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Wang, T., Sun, H., Lu, Z., Jiang, W., Dai, G., Huang, L., Wang, M., Zhu, C., Wang, Y., and Hao, C. (2022). The CARDS toxin of Mycoplasma pneumoniae induces a positive feedback loop of type 1 immune response. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1054788"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Dou, H., Tu, P., Shi, D., Wei, R., Wan, R., Jia, C., Ning, L., Wang, D., and Li, J. (2022). Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1088725"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","article-title":"Chlamydia cell biology and pathogenesis","volume":"14","author":"Elwell","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"ftab014","DOI":"10.1093\/femspd\/ftab014","article-title":"T cell responses to Chlamydia","volume":"79","author":"Helble","year":"2021","journal-title":"Pathog. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00198-20","DOI":"10.1128\/IAI.00198-20","article-title":"Chlamydia lipooligosaccharide has varied direct and indirect roles in evading both innate and adaptive host immune responses","volume":"88","author":"Wang","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1574-695X.2010.00772.x","article-title":"Chlamydiales and the innate immune response: Friend or foe?","volume":"61","author":"Rusconi","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/CDLI.5.3.313-318.1998","article-title":"Analysis of the Humoral Immune Response to Chlamydia Outer Membrane Protein 2","volume":"5","author":"Mygind","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.6061\/clinics\/2012(11)17","article-title":"Biomarkers in community-acquired pneumonia: A state-of-the-art review","volume":"67","author":"Seligman","year":"2012","journal-title":"Clinics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"00014-2019","DOI":"10.1183\/23120541.00014-2019","article-title":"Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: Results of a 5-year follow-up cohort study","volume":"5","author":"Siljan","year":"2019","journal-title":"ERJ Open Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.02.00295102","article-title":"Systemic cytokine levels in community-acquired pneumonia and their association with disease severity","volume":"20","author":"Antunes","year":"2002","journal-title":"Eur. Respir. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155263","DOI":"10.1016\/j.cyto.2020.155263","article-title":"Dynamics of cytokines, immune cell counts, and disease severity in patients with community-acquired pneumonia\u2014Unravelling potential causal relationships","volume":"136","author":"Rosolowski","year":"2020","journal-title":"Cytokine"},{"key":"ref_27","unstructured":"Tille, P.M. (2014). Diagnostic Microbiology, Elsevier. [13th ed.]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2009","journal-title":"Int. Anesthesiol. Clin."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-024-02093-8","article-title":"A pan-immune panorama of bacterial pneumonia revealed by a large-scale single-cell transcriptome atlas","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ding, L., and Jiang, Y. (2025). Biomarkers associated with the diagnosis and prognosis of Mycoplasma pneumoniae pneumonia in children: A review. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1552144"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Karakioulaki, M., and Stolz, D. (2019). Biomarkers in Pneumonia-Beyond Procalcitonin. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20082004"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Carbonell, R., Moreno, G., Mart\u00edn-Loeches, I., Bod\u00ed, M., and Rodr\u00edguez, A. (2023). The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults. Antibiotics, 12.","DOI":"10.3390\/antibiotics12010161"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lin, J., Chen, J., Yuan, S., Tang, M., Yang, G., Zhang, H., Li, W., Zhao, H., Zhang, J., and Zhang, L. (2025). Local and systemic cytokine profiles in children with pneumonia-associated lung consolidation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1546730"},{"key":"ref_35","first-page":"64","article-title":"Mycoplasma pneumoniae and Chlamydia pneumoniae community-acquired pneumonia in young adults from a family medicine practice","volume":"15","author":"Coman","year":"2025","journal-title":"GERMS"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cytogfr.2020.11.003","article-title":"Macrophage-derived cytokines in pneumonia: Linking cellular immunology and genetics","volume":"59","author":"Dukhinova","year":"2021","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1378\/chest.11-1446","article-title":"Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia","volume":"141","author":"Menendez","year":"2012","journal-title":"Chest"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11908-016-0516-y","article-title":"Relevant Cytokines in the Management of Community-Acquired Pneumonia","volume":"18","author":"Rendon","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1183\/09031936.00074410","article-title":"Systemic cytokine response in patients with community-acquired pneumonia","volume":"37","author":"Endeman","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s10753-014-9840-2","article-title":"Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia","volume":"37","author":"Uriarte","year":"2014","journal-title":"Inflammation"},{"key":"ref_41","first-page":"13","article-title":"Analysis of the Local and Systemic Cytokine Response Profiles in Patients with Community-Acquired Pneumonia: Relationship with Outcomes and Disease Severity","volume":"1","author":"Wiemken","year":"2017","journal-title":"Univ. Louisville J. Respir. Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/09031936.00060112","article-title":"Local and systemic cytokine profiles in non-severe and severe community-acquired pneumonia","volume":"41","author":"Paats","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1465-9921-15-75","article-title":"Predicting treatment failure in patients with community-acquired pneumonia: A case-control study","volume":"15","author":"Valles","year":"2014","journal-title":"Respir. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1183\/09031936.00040710","article-title":"Factors associated with inflammatory cytokine patterns in community-acquired pneumonia","volume":"37","author":"Menendez","year":"2011","journal-title":"Eur. Respir. J."},{"key":"ref_45","first-page":"189","article-title":"Systemic interleukin levels in community-acquired pneumonia and their association with adverse outcomes","volume":"27","author":"Tripon","year":"2019","journal-title":"Rev. Rom\u00e2n\u0103 Med. Lab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ppul.24533","article-title":"Evolution of cytokines\/chemokines in cases with community-acquired pneumonia and distinct etiologies","volume":"55","author":"Vasconcellos","year":"2020","journal-title":"Pediatr. Pulmonol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1078\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:50:21Z","timestamp":1760032221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61061078"],"URL":"https:\/\/doi.org\/10.3390\/medicina61061078","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}